SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000898432-23-000827
Filing Date
2023-12-01
Accepted
2023-12-01 16:15:17
Documents
1
Period of Report
2021-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A form4.html 4/A  
1 FORM 4/A form4.xml 4/A 4459
  Complete submission text file 0000898432-23-000827.txt   5821
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BLVD BRIDGEWATER NJ 08807
Business Address
Patel Gautam (Reporting) CIK: 0001738054 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38485 | Film No.: 231459687